- Research works
- 2 fractional, all time
- Citations
- 1 0.6 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 26% world 28%
Not ranked overall: Amdocs (France) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Amdocs (France) publish most on?
By volume in 2022–2025: Acute Lymphoblastic Leukemia research, CAR-T cell therapy research, Chronic Myeloid Leukemia Treatments and Lung Cancer Treatments and Mutations.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 0 works
- 2 CAR-T cell therapy research Oncology 0 works
- 3 Chronic Myeloid Leukemia Treatments Hematology 0 works
- 4 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
- 5 Colorectal Cancer Treatments and Studies Oncology 0 works
- 6 Lung Cancer Research Studies Oncology 0 works
- 7 PARP inhibition in cancer therapy Oncology 0 works
- 8 Orthopedic Surgery and Rehabilitation Surgery 0 works
- 9 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
- 10 Foot and Ankle Surgery Orthopedics and Sports Medicine 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
Other research institutions in Courbevoie
- Fidal
- Saint-Gobain (France)
- Pôle Léonard de Vinci
- Chiesi (France)
- AstraZeneca (France)
- MSD (France)
- Ecole Supérieure d'Ingénieurs Léonard de Vinci
- Informatique Electromagnetisme Electronique Analyse Numerique (France)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.